{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T07:05:39Z","timestamp":1789110339472,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472096"],"award-info":[{"award-number":["82472096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515011968"],"award-info":[{"award-number":["2024A1515011968"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05787-5","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:05:54Z","timestamp":1789106754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantitative dual-layer spectral CT parameters associated with a continuous improvement response pattern to CAPTEM in advanced gastroenteropancreatic neuroendocrine neoplasms"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4134-2943","authenticated-orcid":false,"given":"Jiadan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1236-1188","authenticated-orcid":false,"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1416-9128","authenticated-orcid":false,"given":"Siya","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4640-7073","authenticated-orcid":false,"given":"Zujiang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3435-6959","authenticated-orcid":false,"given":"Tingting","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1233-8717","authenticated-orcid":false,"given":"Jinhui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0916-8822","authenticated-orcid":false,"given":"Jiaxin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1496-5375","authenticated-orcid":false,"given":"Jiawei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8514-020X","authenticated-orcid":false,"given":"Yanji","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"5787_CR1","unstructured":"Network NCC. (2026). NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine and Adrenal Tumors (Version 1.2026). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/neuroendocrine.pdf. Accessed August 28."},{"key":"5787_CR2","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-22-0206","author":"JR Eads","year":"2023","unstructured":"Eads JR, Halfdanarson TR, Asmis T et al (2023) Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. Endocr Relat Cancer https:\/\/doi.org\/10.1530\/ERC-22-0206.","journal-title":"Endocr Relat Cancer"},{"key":"5787_CR3","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1200\/jco.22.01013","volume":"41","author":"PL Kunz","year":"2023","unstructured":"Kunz PL, Graham NT, Catalano PJ et al (2023) Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211). J Clin Oncol 41:1359\u20131369. https:\/\/doi.org\/10.1200\/jco.22.01013.","journal-title":"J Clin Oncol"},{"key":"5787_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026.","journal-title":"Eur J Cancer"},{"key":"5787_CR5","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1007\/s00261-017-1370-6","volume":"43","author":"FJ Maldonado","year":"2018","unstructured":"Maldonado FJ, Sheedy SP, Iyer VR et al (2018) Reproducible imaging features of biologically aggressive gastrointestinal stromal tumors of the small bowel. Abdom Radiol (NY) 43:1567\u20131574. https:\/\/doi.org\/10.1007\/s00261-017-1370-6.","journal-title":"Abdom Radiol (NY)"},{"key":"5787_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1158\/1078-0432.Ccr-08-1476","volume":"15","author":"MH Kulke","year":"2009","unstructured":"Kulke MH, Hornick JL, Frauenhoffer C et al (2009) O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors. Clin Cancer Res 15:338\u2013345. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-08-1476.","journal-title":"Clin Cancer Res"},{"key":"5787_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1148\/radiol.14131480","volume":"271","author":"D Marin","year":"2014","unstructured":"Marin D, Boll DT, Mileto A, Nelson RC (2014) State of the art: dual-energy CT of the abdomen. Radiology 271:327\u2013342. https:\/\/doi.org\/10.1148\/radiol.14131480.","journal-title":"Radiology"},{"key":"5787_CR8","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1007\/s00261-021-03266-7","volume":"47","author":"GV Toia","year":"2022","unstructured":"Toia GV, Mileto A, Wang CL, Sahani DV (2022) Quantitative dual-energy CT techniques in the abdomen. Abdom Radiol (NY) 47:3003\u20133018. https:\/\/doi.org\/10.1007\/s00261-021-03266-7.","journal-title":"Abdom Radiol (NY)"},{"key":"5787_CR9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2214\/ajr.21.27017","volume":"218","author":"Y Wang","year":"2022","unstructured":"Wang Y, Hu X, Shi S et al (2022) Utility of Quantitative Metrics From Dual-Layer Spectral-Detector CT for Differentiation of Pancreatic Neuroendocrine Tumor and Neuroendocrine Carcinoma. AJR Am J Roentgenol 218:999\u20131009. https:\/\/doi.org\/10.2214\/ajr.21.27017.","journal-title":"AJR Am J Roentgenol"},{"key":"5787_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000443167","volume":"103","author":"M Pavel","year":"2016","unstructured":"Pavel M, O\u2019Toole D, Costa F et al (2016) ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site. Neuroendocrinology 103:172\u2013185. https:\/\/doi.org\/10.1159\/000443167.","journal-title":"Neuroendocrinology"},{"key":"5787_CR11","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00261-022-03634-x","volume":"47","author":"A Moleesaide","year":"2022","unstructured":"Moleesaide A, Maneegarn A, Kaewlai R, Thiravit S (2022) Virtual monochromatic spectral attenuation curve analysis for evaluation of incidentally detected small renal lesions using rapid kilovoltage-switching dual-energy computed tomography. Abdom Radiol (NY) 47:3817\u20133827. https:\/\/doi.org\/10.1007\/s00261-022-03634-x.","journal-title":"Abdom Radiol (NY)"},{"key":"5787_CR12","doi-asserted-by":"publisher","first-page":"100119","DOI":"10.1016\/j.esmoop.2021.100119","volume":"6","author":"H Jeong","year":"2021","unstructured":"Jeong H, Shin J, Jeong JH et al (2021) Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index\u2009<\u200955%: single-arm phase II study. ESMO Open 6:100119. https:\/\/doi.org\/10.1016\/j.esmoop.2021.100119.","journal-title":"ESMO Open"},{"key":"5787_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1148\/radiol.2473070414","volume":"247","author":"V Goh","year":"2008","unstructured":"Goh V, Halligan S, Gharpuray A, Wellsted D, Sundin J, Bartram CI (2008) Quantitative assessment of colorectal cancer tumor vascular parameters by using perfusion CT: influence of tumor region of interest. Radiology 247:726\u2013732. https:\/\/doi.org\/10.1148\/radiol.2473070414.","journal-title":"Radiology"},{"key":"5787_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1148\/radiol.2018180544","volume":"289","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zheng C, Yang Z et al (2018) Axillary Sentinel Lymph Nodes in Breast Cancer: Quantitative Evaluation at Dual-Energy CT. Radiology 289:337\u2013346. https:\/\/doi.org\/10.1148\/radiol.2018180544.","journal-title":"Radiology"},{"key":"5787_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-023-01733-3","volume":"129","author":"X Hu","year":"2024","unstructured":"Hu X, Shi S, Wang Y et al (2024) Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas. Radiol Med 129:1\u201313. https:\/\/doi.org\/10.1007\/s11547-023-01733-3.","journal-title":"Radiol Med"},{"key":"5787_CR16","doi-asserted-by":"publisher","first-page":"e220051","DOI":"10.1148\/rycan.220051","volume":"5","author":"J Assouline","year":"2023","unstructured":"Assouline J, Cannella R, Porrello G et al (2023) Volumetric Enhancing Tumor Burden at CT to Predict Survival Outcomes in Patients with Neuroendocrine Liver Metastases after Intra-arterial Treatment. Radiol Imaging Cancer 5:e220051. https:\/\/doi.org\/10.1148\/rycan.220051.","journal-title":"Radiol Imaging Cancer"},{"key":"5787_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2013.11.004","volume":"146","author":"MM Al-Hawary","year":"2014","unstructured":"Al-Hawary MM, Francis IR, Chari ST et al (2014) Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology 146:291\u2013304.e291. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.004.","journal-title":"Gastroenterology"},{"key":"5787_CR18","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1634\/theoncologist.2016-0175","volume":"22","author":"M Ter-Minassian","year":"2017","unstructured":"Ter-Minassian M, Zhang S, Brooks NV et al (2017) Association Between Tumor Progression Endpoints and Overall Survival in Patients with Advanced Neuroendocrine Tumors. Oncologist 22:165\u2013172. https:\/\/doi.org\/10.1634\/theoncologist.2016-0175.","journal-title":"Oncologist"},{"key":"5787_CR19","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1200\/jco.1983.1.11.710","volume":"1","author":"JR Anderson","year":"1983","unstructured":"Anderson JR, Cain KC, Gelber RD (1983) Analysis of survival by tumor response. J Clin Oncol 1:710\u2013719. https:\/\/doi.org\/10.1200\/jco.1983.1.11.710.","journal-title":"J Clin Oncol"},{"key":"5787_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7120565","author":"T Sasaki","year":"2018","unstructured":"Sasaki T, Sugimura Y (2018) The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Na\u00efve Prostate Cancer Patients. J Clin Med https:\/\/doi.org\/10.3390\/jcm7120565.","journal-title":"J Clin Med"},{"key":"5787_CR21","doi-asserted-by":"publisher","first-page":"e1911750","DOI":"10.1001\/jamanetworkopen.2019.11750","volume":"2","author":"T Burzykowski","year":"2019","unstructured":"Burzykowski T, Coart E, Saad ED et al (2019) Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer. JAMA Netw Open 2:e1911750. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.11750.","journal-title":"JAMA Netw Open"},{"key":"5787_CR22","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.2147\/ott.S170722","volume":"11","author":"M Reck","year":"2018","unstructured":"Reck M, Mellemgaard A, Novello S et al (2018) Change in non-small-cell lung cancer tumor size in patients treated with nintedanib plus docetaxel: analyses from the Phase III LUME-Lung 1 study. Onco Targets Ther 11:4573\u20134582. https:\/\/doi.org\/10.2147\/ott.S170722.","journal-title":"Onco Targets Ther"},{"key":"5787_CR23","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1038\/s41598-025-95475-z","volume":"15","author":"OM Otunuga","year":"2025","unstructured":"Otunuga OM (2025) Stochastic modeling and first-passage-time analysis of oncological time metrics with dynamic tumor barriers. Sci Rep 15:14941. https:\/\/doi.org\/10.1038\/s41598-025-95475-z.","journal-title":"Sci Rep"},{"key":"5787_CR24","doi-asserted-by":"publisher","first-page":"937","DOI":"10.3348\/kjr.2024.0589","volume":"25","author":"S Kim","year":"2024","unstructured":"Kim S, Kim MJ, Choe J (2024) Duration of Response as Clinical Endpoint: A Quick Guide for Clinical Researchers. Korean J Radiol 25:937\u2013941. https:\/\/doi.org\/10.3348\/kjr.2024.0589.","journal-title":"Korean J Radiol"},{"key":"5787_CR25","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182\u2013188. https:\/\/doi.org\/10.1111\/his.13975.","journal-title":"Histopathology"},{"key":"5787_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00280-012-2055-z","volume":"71","author":"RL Fine","year":"2013","unstructured":"Fine RL, Gulati AP, Krantz BA et al (2013) Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience. Cancer Chemother Pharmacol 71:663\u2013670. https:\/\/doi.org\/10.1007\/s00280-012-2055-z.","journal-title":"Cancer Chemother Pharmacol"},{"key":"5787_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.6004\/jnccn.2021.7017","volume":"20","author":"T Al-Toubah","year":"2021","unstructured":"Al-Toubah T, Pelle E, Valone T, Haider M, Strosberg JR (2021) Efficacy and Toxicity Analysis of Capecitabine and Temozolomide in Neuroendocrine Neoplasms. J Natl Compr Canc Netw 20:29\u201336. https:\/\/doi.org\/10.6004\/jnccn.2021.7017.","journal-title":"J Natl Compr Canc Netw"},{"key":"5787_CR28","doi-asserted-by":"publisher","first-page":"3830","DOI":"10.1007\/s00261-026-05375-7","volume":"51","author":"H Song","year":"2026","unstructured":"Song H, Wei L, Tan Q et al (2026) Qualitative and quantitative analysis of enhanced computed tomography in differentiating and grading pancreatic neuroendocrine neoplasms: a multicenter study. Abdom Radiol (NY) 51:3830\u20133840. https:\/\/doi.org\/10.1007\/s00261-026-05375-7.","journal-title":"Abdom Radiol (NY)"},{"key":"5787_CR29","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s00330-024-11290-6","volume":"35","author":"Y Chen","year":"2025","unstructured":"Chen Y, Liu X, Zeng H et al (2025) The clinical applications of dual-layer spectral detector CT in digestive system diseases. Eur Radiol 35:3547\u20133557. https:\/\/doi.org\/10.1007\/s00330-024-11290-6.","journal-title":"Eur Radiol"},{"key":"5787_CR30","doi-asserted-by":"publisher","unstructured":"Oberg K (2011) Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 18 Suppl 1:S17\u201325. https:\/\/doi.org\/10.1530\/erc-10-0280.","DOI":"10.1530\/erc-10-0280"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05787-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05787-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05787-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:05:58Z","timestamp":1789106758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05787-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":30,"alternative-id":["5787"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05787-5","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee of the first affiliated hospital of Sun Yat-sen University (approval number: 2021 [721]).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}